Yi He

241 West Huaihai Road
Huaihai, 200030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

FBXL6 drives tumorigenesis in lung adenocarcinoma through ubiquitination and proteasomal degradation of CDKN1C.

FBXL6 drives tumorigenesis in lung adenocarcinoma through ubiquitination and proteasomal degradation of CDKN1C.

Journal: Experimental cell research

Published: July 01, 2025

Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy.

Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy.

Journal: Trials

Published: April 12, 2025

Prognostic value of middle paraesophageal lymph node metastasis in patients with pathologic N+ esophageal squamous cell carcinoma.

Prognostic value of middle paraesophageal lymph node metastasis in patients with pathologic N+ esophageal squamous cell carcinoma.

Journal: International journal of surgery (London, England)

Published: April 02, 2025

Risk factors and prediction of intensive care unit readmission after oesophagectomy for cancer‡.

Risk factors and prediction of intensive care unit readmission after oesophagectomy for cancer‡.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: December 04, 2024

Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma.

Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma.

Journal: Thoracic cancer

Published: September 22, 2024

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial).

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial).

Journal: BMC cancer

Published: October 23, 2023

High cervical anastomosis reduces leakage-related complications after a McKeown esophagectomy.

High cervical anastomosis reduces leakage-related complications after a McKeown esophagectomy.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: October 10, 2023

Radiofrequency Ablation of Unifocal Papillary Thyroid Microcarcinoma With BRAF V600E Mutation.

Radiofrequency Ablation of Unifocal Papillary Thyroid Microcarcinoma With BRAF V600E Mutation.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 07, 2023

Significance of radiofrequency ablation in large solid benign thyroid nodules.

Significance of radiofrequency ablation in large solid benign thyroid nodules.

Journal: Frontiers in endocrinology

Published: July 12, 2022

Prone position thoracoscopic-assisted total mesoesophageal excision: initial experiences and benefits of lymph node dissection.

Prone position thoracoscopic-assisted total mesoesophageal excision: initial experiences and benefits of lymph node dissection.

Journal: Surgical endoscopy

Published: April 29, 2022

Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).

Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).

Journal: BMC cancer

Published: April 06, 2022

LncRNA JPX Promotes Esophageal Squamous Cell Carcinoma Progression by Targeting miR-516b-5p/VEGFA Axis.

LncRNA JPX Promotes Esophageal Squamous Cell Carcinoma Progression by Targeting miR-516b-5p/VEGFA Axis.

Journal: Cancers

Published: March 29, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026